Dr Parmesh Gajjar is the Chief Technology Officer at InformiX Pharma. Here, he uses his expertise in X-ray Computed Tomography of pharmaceutical materials to enable the pharmaceutical industry to gain a deeper understanding of formulation microstructure, giving faster product development. Dr Gajjar has a Master of Mathematics degree (2010) from the University of Cambridge and a PhD in Applied Mathematics (2016) from the University of Manchester. Parmesh’s first science position was in the National Facility for X-ray Computed Tomography at the University of Manchester, working on characterizing formulated pharmaceutical products using X-ray Computed Tomography. As part of this work, Parmesh has spoken at a number of international conferences, including several RDD conferences. Parmesh has industrial experience working for a CRO, where he wrote several supporting reports for regulatory submissions and is listed on one patent. Dr. Gajjar was an invited speaker at the joint CRCG/FDA workshop in 2021 on establishing model integrated evidence for product assessment. In 2023, Parmesh was nominated by the Academy of Pharmaceutical Sciences UK for the international FIP Early Career In Pharmaceutical Science Recognition Award.
